Literature DB >> 28655058

Association of Socioeconomic Status in Childhood With Left Ventricular Structure and Diastolic Function in Adulthood: The Cardiovascular Risk in Young Finns Study.

Tomi T Laitinen1,2, Elina Puolakka1, Saku Ruohonen1, Costan G Magnussen1,3, Kylie J Smith1, Jorma S A Viikari4, Olli J Heinonen2, Noora Kartiosuo1, Nina Hutri-Kähönen5, Mika Kähönen6, Eero Jokinen7, Tomi P Laitinen8, Päivi Tossavainen9, Laura Pulkki-Råback10,11, Marko Elovainio11, Olli T Raitakari1,12, Katja Pahkala1,2, Markus Juonala1,4.   

Abstract

Importance: Increased left ventricular (LV) mass and diastolic dysfunction are associated with cardiovascular disease. Prospective data on effects of childhood socioeconomic status (SES) on measures of LV structure and function are lacking. Objective: To examine whether family SES in childhood was associated with LV mass and diastolic function after adjustment for conventional cardiovascular disease risk factors in childhood and adulthood. Design, Setting, and Participants: The analyses were performed in 2016 using data gathered in 1980 and 2011 within the longitudinal population-based Cardiovascular Risk in Young Finns Study. The sample comprised 1871 participants who reported family SES at ages 3 to 18 years and were evaluated for LV structure and function 31 years later. Exposures: Socioeconomic status was characterized as annual income of the family and classified on a 3-point scale. Main Outcomes and Measures: Left ventricular mass indexed according to height at the allometric power of 2.7 and the E/e' ratio describing LV diastolic performance at ages 34 to 49 years.
Results: The participants were aged 3 to 18 years at baseline (mean [SD], 10.8 [5.0] years), and the length of follow-up was 31 years. Family SES was inversely associated with LV mass (mean [SD] LV mass index, 31.8 [6.7], 31.0 [6.6], and 30.1 [6.4] g/m2.7 in the low, medium, and high SES groups, respectively; differences [95% CI], 1.7 [0.6 to 2.8] for low vs high SES; 0.8 [-0.3 to 1.9] for low vs medium; and 0.9 [0.1 to 1.6] for medium vs high; overall P = .001) and E/e' ratio (mean [SD] E/e' ratio, 5.0 [1.0], 4.9 [1.0], and 4.7 [1.0] in the low, medium, and high SES groups, respectively; differences [95% CI], 0.3 [0.1 to 0.4] for low vs high SES; 0.1 [-0.1 to 0.3] for low vs medium; and 0.2 [0 to 0.3] for medium vs high; overall P < .001) in adulthood. After adjustment for age, sex, and conventional cardiovascular disease risk factors in childhood and adulthood, and participants' own SES in adulthood, the relationship with LV mass (differences [95% CI], 1.5 [0.2 to 2.8] for low vs high SES; 1.3 [0 to 2.6] for low vs medium; and 0.2 [-0.6 to 1.0] for medium vs high; P = .03) and E/e' ratio (differences [95% CI], 0.2 [0 to 0.5] for low vs high SES; 0.1 [-0.1 to 0.4] for low vs medium; and 0.1 [0 to 0.3] for medium vs high; P = .02) remained significant. Conclusions and Relevance: Low family SES was associated with increased LV mass and impaired diastolic performance more than 3 decades later. These findings emphasize that approaches of cardiovascular disease prevention must be directed also to the family environment of the developing child.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28655058      PMCID: PMC5710638          DOI: 10.1001/jamapediatrics.2017.1085

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  30 in total

1.  Relation between socioeconomic status, race-ethnicity, and left ventricular mass: the Northern Manhattan study.

Authors:  Carlos J Rodriguez; Robert R Sciacca; Ana V Diez-Roux; Bernadette Boden-Albala; Ralph L Sacco; Shunichi Homma; Marco R DiTullio
Journal:  Hypertension       Date:  2004-02-23       Impact factor: 10.190

2.  Cohort profile: the cardiovascular risk in Young Finns Study.

Authors:  Olli T Raitakari; Markus Juonala; Tapani Rönnemaa; Liisa Keltikangas-Järvinen; Leena Räsänen; Matti Pietikäinen; Nina Hutri-Kähönen; Leena Taittonen; Eero Jokinen; Jukka Marniemi; Antti Jula; Risto Telama; Mika Kähönen; Terho Lehtimäki; Hans K Akerblom; Jorma S A Viikari
Journal:  Int J Epidemiol       Date:  2008-02-08       Impact factor: 7.196

3.  Progression of left ventricular diastolic dysfunction and risk of heart failure.

Authors:  Garvan C Kane; Barry L Karon; Douglas W Mahoney; Margaret M Redfield; Veronique L Roger; John C Burnett; Steven J Jacobsen; Richard J Rodeheffer
Journal:  JAMA       Date:  2011-08-24       Impact factor: 56.272

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.

Authors:  Andrew S P Sharp; Robyn J Tapp; Simon A McG Thom; Darrel P Francis; Alun D Hughes; Alice V Stanton; Andrew Zambanini; Eoin O'Brien; Nish Chaturvedi; Simon Lyons; Sheila Byrd; Neil R Poulter; Peter S Sever; Jamil Mayet
Journal:  Eur Heart J       Date:  2009-11-26       Impact factor: 29.983

6.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

7.  Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study).

Authors:  Ahmet Toprak; Hongwei Wang; Wei Chen; Timir Paul; Sathanur Srinivasan; Gerald Berenson
Journal:  Am J Cardiol       Date:  2008-04-02       Impact factor: 2.778

8.  Reference Values for Echocardiography in Middle-Aged Population: The Cardiovascular Risk in Young Finns Study.

Authors:  Saku Ruohonen; Juha W Koskenvuo; Maria Wendelin-Saarenhovi; Mikko Savontaus; Mika Kähönen; Tomi Laitinen; Terho Lehtimäki; Eero Jokinen; Jorma Viikari; Markus Juonala; Leena Taittonen; Päivi Tossavainen; Merja Kallio; Jeroen J Bax; Olli Raitakari
Journal:  Echocardiography       Date:  2015-08-01       Impact factor: 1.724

Review 9.  Heart failure and socioeconomic status: accumulating evidence of inequality.

Authors:  Nathaniel M Hawkins; Pardeep S Jhund; John J V McMurray; Simon Capewell
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

10.  Inequalities in heart failure in older men: prospective associations between socioeconomic measures and heart failure incidence in a 10-year follow-up study.

Authors:  Sheena E Ramsay; Peter H Whincup; Olia Papacosta; Richard W Morris; Lucy T Lennon; S Goya Wannamethee
Journal:  Eur Heart J       Date:  2013-10-18       Impact factor: 29.983

View more
  4 in total

Review 1.  Social, Economic, Technological, and Environmental Factors Affecting Cardiovascular Diseases: A Systematic Review and Thematic Analysis.

Authors:  Gisoo Alizadeh; Kamal Gholipour; Saber Azami-Aghdash; Reza Dehnavieh; Mohammad Asghari JafarAbadi; Mehrdad Azmin; Rahim Khodayari-Zarnaq
Journal:  Int J Prev Med       Date:  2022-04-27

2.  Social status and susceptibility to wildfire smoke among outdoor-housed female rhesus monkeys: A natural experiment.

Authors:  Heng Bai; John P Capitanio; Lisa A Miller; Jane E Clougherty
Journal:  Heliyon       Date:  2021-11-09

Review 3.  Lifestyle, inadequate environments in childhood and their effects on adult cardiovascular health.

Authors:  Isabela de Carlos Back; Nelson Filice de Barros; Bruno Caramelli
Journal:  J Pediatr (Rio J)       Date:  2021-11-19       Impact factor: 2.990

4.  Blood pressure variability and night-time dipping assessed by 24-hour ambulatory monitoring: Cross-sectional association with cardiac structure in adolescents.

Authors:  Lucy J Goudswaard; Sean Harrison; Daniel Van De Klee; Nishi Chaturvedi; Debbie A Lawlor; George Davey Smith; Alun D Hughes; Laura D Howe
Journal:  PLoS One       Date:  2021-06-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.